» Articles » PMID: 35846872

Awareness and Perception of Hospitalized Patients on Thromboembolism and Thromboprophylaxis: A Cross-Sectional Study in Sana'a-Yemen

Overview
Date 2022 Jul 18
PMID 35846872
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Patients' awareness toward VTE and thromboprophylaxis is critical for medication adherence. This study aimed to evaluate the patient's awareness and perception towards VTE and its prophylaxis and to assess patient's satisfaction towards the information given by the medical staff.

Participants And Methods: A cross-sectional survey was conducted among hospitalized patients who received VTE prophylaxis in public and private hospitals in Sana'a, Yemen. Besides sociodemographic variables, participants' awareness and perception of VTE and its prophylaxis were evaluated. Variables' association with VTE awareness were analyzed using univariable and multivariable logistic regression using SPSS.

Results: A total of 396 of the hospitalized patients agreed to participate in the study, with 31% (n = 121) have ever heard about VTE. The multivariable logistic regression findings revealed that the participants who did not have a profession had OR = 17.182 ( < 0.001) of being unaware of VTE compared with those who had one. Participants who did not have a personal history of VTE had OR = 7.580 ( < 0.001) of being unaware of DVT/PE compared with the participants who had a personal history of VTE. Male participants had OR = 2.839 ( < 0.005) of being unaware of DVT/PE compared with female participants. Participants who were illiterate had OR = 2.832 ( < 0.022) of being unaware of DVT/PE compared with participants with a higher level of education.

Conclusion: The study revealed lack of awareness and perception of VTE and its prophylaxis among hospitalized patients in Yemen. The patients who are unaware of the disease have wrong perception about their role in DVT prophylaxis. Patient's education must be considered in healthcare setting to improve patient's health outcomes.

Citing Articles

Barriers and facilitators to the implementation of guidelines for venous thromboembolism prevention and management: A mixed-methods systematic review.

Han M, Huang J, Yang J, Chen J, Qi H Int J Nurs Stud Adv. 2024; 8:100273.

PMID: 39717799 PMC: 11664414. DOI: 10.1016/j.ijnsa.2024.100273.


Adequacy of Venous Thromboembolism Risk Assessment and Prophylaxis After Gastrointestinal Surgery in a Sudanese Teaching Hospital: A Prospective Audit.

Hassan M, Adam R, Hussen Mostafa Adam M, Mairghani R, Ahmed A, Abdelseid H Cureus. 2024; 16(11):e73316.

PMID: 39659353 PMC: 11628196. DOI: 10.7759/cureus.73316.


Awareness, Knowledge, and Practices for Preventing Deep Vein Thrombosis in Al Qunfudhah, Saudi Arabia: A Cross-Sectional Study.

Taha M, Aldirhami I, Habili M, Alkinani I, Bamusa H, Alhasani F Cureus. 2024; 16(8):e66438.

PMID: 39246991 PMC: 11380646. DOI: 10.7759/cureus.66438.

References
1.
Folsom A, Cushman M . Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?. J Am Heart Assoc. 2020; 9(23):e019395. PMC: 7763794. DOI: 10.1161/JAHA.120.019395. View

2.
Konieczynska M, Sobieraj E, Bryk A, Debski M, Polak M, Podolec P . Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists. Kardiol Pol. 2018; 76(7):1089-1096. DOI: 10.5603/KP.a2018.0069. View

3.
Piazza G, Nguyen T, Morrison R, Cios D, Hohlfelder B, Fanikos J . Patient education program for venous thromboembolism prevention in hospitalized patients. Am J Med. 2012; 125(3):258-64. DOI: 10.1016/j.amjmed.2011.09.012. View

4.
Al Bshabshe A, Mousa W, Alshehri M, Saeed Alshahrani M, Alamri O, Alshehri F . Awareness, knowledge, and attitude toward venous thromboembolism among Aseer Population, Saudi Arabia. J Family Med Prim Care. 2021; 10(6):2411-2415. PMC: 8284245. DOI: 10.4103/jfmpc.jfmpc_2430_20. View

5.
Yi Y, Gong S, Gong T, Zhou L, Hu C, Xu W . New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis. Front Pharmacol. 2022; 12:775126. PMC: 8801787. DOI: 10.3389/fphar.2021.775126. View